Literature DB >> 1739195

Hemorrhagic infarct conversion in experimental stroke.

G M de Courten-Myers1, M Kleinholz, P Holm, G DeVoe, G Schmitt, K R Wagner, R E Myers.   

Abstract

STUDY
OBJECTIVE: This study investigated the relations between hemorrhagic infarction and occlusion, release, levels of glycemia, brain energy state, and lactate content after cerebrovascular occlusion.
DESIGN: Prospective, controlled laboratory investigation. TYPE OF PARTICIPANTS: One hundred six pentobarbital-anesthetized cats.
INTERVENTIONS: The middle cerebral artery was occluded with a Yasargil clip transorbitally either temporarily (0.5, four, and eight hours) or permanently. Normoglycemic and hyperglycemic animals were closely monitored for eight hours. Brain pathology was assessed after two weeks' survival or at the time of spontaneous animal death. Topographic brain metabolite studies were carried out after four hours of middle cerebral artery occlusion.
MEASUREMENTS AND MAIN RESULTS: Morphometric quantitation of cerebral hemorrhage and infarction and fluorometric determinations of blood and brain tissue, glucose, glycogen, lactate, adenosine triphosphate, and phosphocreatine from 16 topographic brain sites were carried out. Twenty-one of 82 (25.6%) animals evaluated neuropathologically showed hemorrhagic infarcts. Occluding the artery in hyperglycemic animals caused fivefold more frequent and 25-fold more extensive hemorrhage into infarcts than in normoglycemic animals. Temporary occlusion with clip release after four hours in hyperglycemic animals caused the most extensive hemorrhage into infarcts. Most hemorrhages into infarcts (81%) took place in animals that died within a few hours after they experienced ischemia and that showed infarction and marked edema of the entire middle cerebral artery territory. Linear regression analyses demonstrated a close relation between hemorrhage into infarcts and near-total energy depletion (adenosine triphosphate, less than 0.3 microM/g; phosphocreatine, less than 0.5 microM/g) in brain sites that showed extremely high tissue lactate concentrations (more than 30 microM/g). The biochemical changes that correlated with hemorrhage into infarcts were more marked than those with infarcts without hemorrhage.
CONCLUSION: Hyperglycemia and restoration of blood flow to ischemic territories were strong risk factors for hemorrhagic infarct conversion. Concomitant tissue metabolic changes suggest that marked tissue energy depletion accompanied by acidosis damages brain vessels and renders them penetrable for edema fluid and, ultimately, red blood cell extravasation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1739195     DOI: 10.1016/s0196-0644(05)80144-1

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  22 in total

1.  Endothelin-1-mediated cerebrovascular remodeling is not associated with increased ischemic brain injury in diabetes.

Authors:  Weiguo Li; Aisha I Kelly-Cobbs; Erin M Mezzetti; Susan C Fagan; Adviye Ergul
Journal:  Can J Physiol Pharmacol       Date:  2010-08       Impact factor: 2.273

2.  Treatment of malignant brain edema and increased intracranial pressure after stroke.

Authors:  Michael E Brogan; Edward M Manno
Journal:  Curr Treat Options Neurol       Date:  2015-01       Impact factor: 3.598

3.  Potential link between post-acute ischemic stroke exposure to hypoglycemia and hemorrhagic transformation.

Authors:  Kyle D Klingbeil; Sebastian Koch; Kunjan R Dave
Journal:  Int J Stroke       Date:  2017-11-14       Impact factor: 5.266

Review 4.  Considering hyperglycemia and thrombolysis in the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial.

Authors:  Andrew M Southerland; Karen C Johnston
Journal:  Ann N Y Acad Sci       Date:  2012-09       Impact factor: 5.691

5.  Neurovascular injury in acute hyperglycemia and diabetes: A comparative analysis in experimental stroke.

Authors:  Mostafa M Elgebaly; Safia Ogbi; Weiguo Li; Erin M Mezzetti; Roshini Prakash; Maribeth H Johnson; Askiel Bruno; Susan C Fagan; Adviye Ergul
Journal:  Transl Stroke Res       Date:  2011-09       Impact factor: 6.829

Review 6.  Hemorrhagic transformation after ischemic stroke in animals and humans.

Authors:  Glen C Jickling; DaZhi Liu; Boryana Stamova; Bradley P Ander; Xinhua Zhan; Aigang Lu; Frank R Sharp
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-27       Impact factor: 6.200

7.  Diabetes mellitus, acute hyperglycemia, and ischemic stroke.

Authors:  Askiel Bruno; David Liebeskind; Qing Hao; Radoslav Raychev
Journal:  Curr Treat Options Neurol       Date:  2010-11       Impact factor: 3.598

8.  Anticoagulation after cardioembolic stroke: to bridge or not to bridge?

Authors:  Hen Hallevi; Karen C Albright; Sheryl Martin-Schild; Andrew D Barreto; Sean I Savitz; Miguel A Escobar; Nicole R Gonzales; Elizabeth A Noser; Kachi Illoh; James C Grotta
Journal:  Arch Neurol       Date:  2008-07-14

9.  Effects of deferoxamine on brain injury after transient focal cerebral ischemia in rats with hyperglycemia.

Authors:  Yingqi Xing; Ya Hua; Richard F Keep; Guohua Xi
Journal:  Brain Res       Date:  2009-07-23       Impact factor: 3.252

10.  When hypothermia meets hypotension and hyperglycemia: the diverse effects of adenosine 5'-monophosphate on cerebral ischemia in rats.

Authors:  Feng Zhang; Suping Wang; Yumin Luo; Xunming Ji; Edwin M Nemoto; Jun Chen
Journal:  J Cereb Blood Flow Metab       Date:  2009-03-25       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.